1. Clusterin as a Potential Biomarker of Obesity-Related Alzheimer’s Disease Risk
   David Bradley, 2020, Biomarker Insights CrossRef
2. Predictors for survival in patients with Alzheimer’s disease: a large comprehensive meta-analysis
   Xiaoting Zheng et al, 2024, Translational Psychiatry CrossRef
3. Examining the effects of the CLU and APOE polymorphisms' combination on coronary artery disease complexed with type 2 diabetes mellitus
   Aybike Sena Ozuynuk et al, 2022, Journal of Diabetes and its Complications CrossRef
4. A Role for Clusterin in Exfoliation Syndrome and Exfoliation Glaucoma?
   Janey L. Wiggs et al, 2018, Journal of Glaucoma CrossRef
5. Accumulation of Cerebrospinal Fluid Glycerophospholipids and Sphingolipids in Cognitively Healthy Participants With Alzheimer’s Biomarkers Precedes Lipolysis in the Dementia Stage
   Alfred N. Fonteh et al, 2020, Frontiers in Neuroscience CrossRef
6. The Role of Genetics in Alzheimer's Disease and Parkinson's Disease
   Tenielle Porter et al, 2019, Neurodegeneration and Alzheimer's Disease CrossRef
7. Updated Meta-Analysis of BIN1, CR1, MS4A6A, CLU, and ABCA7 Variants in Alzheimer’s Disease
   Jucimara Ferreira Figueiredo Almeida et al, 2018, Journal of Molecular Neuroscience CrossRef
8. Genetic factors related to the immune system in subjects at risk of developing Alzheimer's disease
   Michał Prendecki et al, 2020, Journal of Integrative Neuroscience CrossRef
9. Association study of polymorphisms in ABCA7, clusterin, and MS4A6A genes with Alzheimer’s disease in the Egyptian population
   Hanem G. Abd Elrahman et al, 2020, Turkish Journal of Biochemistry CrossRef
10. Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other Pathologies
    Evangeline M. Foster et al, 2019, Frontiers in Neuroscience CrossRef
11. Analyzing 74,248 Samples Confirms the Association Between CLU rs11136000 Polymorphism and Alzheimer’s Disease in Caucasian But Not Chinese population
    Zhijie Han et al, 2018, Scientific Reports CrossRef
12. Defective Lysosomal Lipid Catabolism as a Common Pathogenic Mechanism for Dementia
    Jun Yup Lee et al, 2021, NeuroMolecular Medicine CrossRef
13. Structural Covariance Network as an Endophenotype in Alzheimer’s Disease-Susceptible Single-Nucleotide Polymorphisms and the Correlations With Cognitive Outcomes
    Hsin-I Chang et al, 2021, Frontiers in Aging Neuroscience CrossRef
14. Association between clusterin concentration and dementia: a systematic review and meta-analysis
    Caiping Yang et al, 2019, Metabolic Brain Disease CrossRef
15. Associations between CLU polymorphisms and memory performance: The role of serum lipids in Alzheimer's disease
    Lu Hua Chen et al, 2020, Journal of Psychiatric Research CrossRef
16. Knowledge domains and emerging trends of Genome-wide association studies in Alzheimer’s disease: A bibliometric analysis and visualization study from 2002 to 2022
    Fanjing Kong et al, 2024, PLOS ONE CrossRef